RecallRadar

FDA Device recall Z-0671-2020

Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is intended for the quantitative in vitro determin…

On 2019-12-18 the FDA classified a Class II recall of Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is intended for the quantitative in vitro determin… by The Binding Site Group, citing deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0671-2020
ClassificationClass II
Statusterminated
Initiated2019-02-19
Published2019-12-18
Last updated2026-09-13 11:55 UTC
CompanyThe Binding Site Group
DistributionUS

Product

Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is intended for the quantitative in vitro determination of C-reactive protein (CRP) concentration in serum using the Binding Site Optilite analyser. Measurement of C-Reactive Protein aids in evaluation of the amount of injury to body tissues and for evaluation of infection, tissue injury, and inflammatory disorders. This test should be used in conjunction with other laboratory and clinical findings. The Optilite C-Reactive Protein Calibrator is intended for the calibration of the Optilite C-Reactive Protein Reagent on the Optilite analyser. The Optilite C-Reactive Protein Controls are intended for use in quality control by monitoring accuracy and precision for the Optilite C-Reactive Protein Reagent.

Reason

Deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits

Identifiers

code_infoModel Number: NK044.OPT.A Lot 437705 UDI 05051700018449 Medical Device Listing number D317086

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0671-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.